Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for BYSI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 50.63M
March 31, 2026 48.76M
December 31, 2025 49.92M
September 30, 2025 49.29M
June 30, 2025 48.59M
March 31, 2025 49.77M
December 31, 2023
September 30, 2023
June 30, 2023
March 31, 2023
December 31, 2022
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021 55.27M
September 30, 2021 59.21M
June 30, 2021 24.74M
March 31, 2021 21.52M
Date Value
December 31, 2020 25.22M
September 30, 2020 16.47M
June 30, 2020 15.10M
March 31, 2020 15.51M
December 31, 2019 13.42M
September 30, 2019 11.86M
June 30, 2019 24.10M
March 31, 2019 24.88M
December 31, 2018 16.44M
September 30, 2018
June 30, 2018 5.684M
March 31, 2018 5.802M
December 31, 2017 4.792M
September 30, 2017 3.081M
June 30, 2017 3.212M
March 31, 2017 1.93M
December 31, 2016 2.609M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 436.29M
Alnylam Pharmaceuticals, Inc. 4.205B
Anika Therapeutics, Inc. 46.19M
Savara, Inc. 48.48M
Vericel Corp. 132.82M

Total Liabilities (Quarterly) Related Metrics